COVID-19 Research Visit UCLB’s dedicated e-lucid site to access free technologies for tackling COVID-19. READ MORE Image Credit: James Tye/UCL > OUR TECHNOLOGIES We market UCL innovations that have a real and positive impact on people's lives. READ MORE OUR SPINOUTS We’re committed to supporting and nurturing our spinouts. READ MORE SUPPORT FOR RESEARCHERS We’re ideally positioned to help and guide you at every step of your journey from innovation to impact. READ MORE
What we do—

Changing the world

UCLB is the commercialisation company of UCL and its partner NHS Trusts. We bring to market truly world-leading, world-changing technologies, innovations that have a real and positive impact on people’s lives.

Read More
Latest news—

UCL Technology Fund announces first close of £100m Fund 2

Read More
Featured Technology—

Softscreen – a shape-shifting capsule robot for gi endoscopy

Soft Shape-shifting Capsule Robot for Endoscopy based on Eversion Navigation (SoftSCREEN). A novel design for a capsule robotic system that propels itself through the gastrointestinal (GI) tract by means of a series of continuously everting elastic tracks (i.e. the tracks go from the inside of the capsule to the outside in a continuous manner) distributed all around its body.

Read more
Spotlight—

An introduction to UCLB’s new Associate Director of BioPharm

We recently interviewed Associate Director of BioPharm, Dr Mark Fisher, about his new position, the ever-developing field of technology transfer, and the importance of commercialisation in society today.

Read More
Featured Technology—

SnakeGrid

SnakeGrid is a way of developing low-distortion coordinate systems for large engineering projects.

Read more

Latest news and highlights

Read More News

Top US, UK, and EU universities working together to help economies fuel post-COVID recovery

/ UCLB News
Ten world-leading US, UK, and EU universities will discuss with leaders in national governments and funding bodies on how to ...

Odin Vision receives NIHR funding to accelerate its AI technology for patient benefit

/ Spinout News
NIHR (National Institute for Health Research) has recognised Odin Vision as one of the companies to benefit from its new ...

Freeline announces pricing of initial public offering

/ Spinout News
Freeline Therapeutics has announced the pricing of its initial public offering in the United States of 8,823,529 American Depositary Shares ...

Bramble energy secures significant new capital to accelerate its unique fuel cell deployment

/ Spinout News, UCLTF News
Bramble Energy, the world’s most scalable hydrogen fuel cell company has raised a £5m Series A round. BGF led the ...

FIND THE RIGHT MATCH

Whether you’re an academic or looking for technologies, find your UCLB contact here.

 

Commercialising technology since 1993

0
Spinout companies in the UCLB portfolio
0
Active licences
0
Drug discovery projects in development
0
New UK patent applications

As of July 2019

"With UCLB's excellent advice, support and business expertise TrimTots is running and ready to roll!" Dr Julie Lanigan, Co-Founder of TrimTots "We could not have done this without UCLB. Their advice, guidance and expertise was invaluable" Professor Bobby Gaspar, Chief Scientific Officer, Orchard Therapeutics "UCLB’s input and support have been invaluable. Professional, expert and a pleasure to work with" Professor Elizabeth Murray, Founder of HeLP Digital CIC "UCLB are business savvy but also have a sensitive understanding of research. I am very grateful and significantly wealthier!" Professor Anthony Finkelstein, Systemwire/Message Automation “The valuable advice and support UCLB provided us with gave us the confidence and infrastructure to launch the Print Fair” Professor Susan Collins, Slade School of Fine Art Photo Jim Wileman © 2015 Royal Albert Memorial Museum & Art Gallery, Exeter City Council “UCLB are a great source of talent, expertise and experience, and have been super helpful for us over the years” Dr Daniel Hulme, CEO of Satalia "UCLB's experience and advice has proved pivotal in our development as a company" Rael Cline, CEO of MediaGamma